In this episode of Getting Down to Business, host Kadie DiGiuseppe goes over:
- Novo Nordisk's Ozempic being approved to treat kidney disease in people with Type 2 diabetes.
- Starbucks looking to make a comeback after its fiscal year results were announced.
- 23andMe announcing it will be exploring alternatives after the company has faced a decline in sales.
